You are here:

Molecular Diagnostics

D3 Technologies Ltd, a subsidiary of Renishaw plc, are a new molecular diagnostics company with a specific interest in clinical diagnostics.  D3 Technologies use a new detection method based on bio-nanotechnology to produce high performance analysis systems for the clinical diagnostics market and for related markets such as in the pharmaceutical industry. 

For further information and current vacancies, please see their website: www.d3technologies.co.uk

.

Next steps

Contact us online if you require more information or you have a pricing query, or alternatively you may like to speak directly to your local Renishaw office.